Cargando…
Mass spectrometry‐based characterization of histones in clinical samples: applications, progress, and challenges
In the last 15 years, increasing evidence linking epigenetics to various aspects of cancer biology has prompted the investigation of histone post‐translational modifications (PTMs) and histone variants in the context of clinical samples. The studies performed so far demonstrated the potential of thi...
Autores principales: | Noberini, Roberta, Robusti, Giulia, Bonaldi, Tiziana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9291046/ https://www.ncbi.nlm.nih.gov/pubmed/33415821 http://dx.doi.org/10.1111/febs.15707 |
Ejemplares similares
-
Investigating pathological epigenetic aberrations by epi-proteomics
por: Robusti, Giulia, et al.
Publicado: (2022) -
Pathology Tissue-quantitative Mass Spectrometry Analysis to Profile Histone Post-translational Modification Patterns in Patient Samples
por: Noberini, Roberta, et al.
Publicado: (2016) -
Mass-spectrometry analysis of histone post-translational modifications in pathology tissue using the PAT-H-MS approach
por: Noberini, Roberta, et al.
Publicado: (2016) -
Label-Free Mass Spectrometry-Based Quantification of Linker Histone H1 Variants in Clinical Samples
por: Noberini, Roberta, et al.
Publicado: (2020) -
A truncated and catalytically inactive isoform of KDM5B histone demethylase accumulates in breast cancer cells and regulates H3K4 tri-methylation and gene expression
por: Di Nisio, Elena, et al.
Publicado: (2023)